Global financial markets are buzzing with widespread anticipation as the Federal Reserve is expected to implement its first interest rate cut of 2025 this week. A 25-basis-point reduction, largely priced in by investors, is slated to adjust the target range for the federal funds rate to 4.00%-4.25%
Since September 2020, the S&P 500 has delivered a total return of 96.5%. But one standout stock has more than doubled the market - over the past five years, PJT has surged 203% to $180.50 per share. Its momentum hasn’t stopped as it’s also gained 29.2% in the last six months thanks to its solid quarterly results, beating the S&P by 12.9%.
The cryptocurrency investment landscape is undergoing a significant transformation, moving beyond the foundational direct spot exposure to embrace a new generation of Exchange-Traded Funds (ETFs). This innovative wave introduces products designed to cater to a broader spectrum of investor appetites and financial objectives. The emergence of crypto index ETFs, leveraged
Bitcoin, the world's leading cryptocurrency, is once again making headlines as its price approaches its all-time high, currently trading robustly around $115,000 to $116,000. This remarkable rally, pushing Bitcoin within approximately 7% of its August 2025 peak of $124,290.93, is being primarily fueled by a potent
Shares of electricity generation and hydrogen production company Bloom Energy (NYSE:BE) jumped 6.5% in the morning session after Morgan Stanley significantly raised its price target on the company, citing its growing potential in the AI data center market.
Looking back on investment banking & brokerage stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including PJT (NYSE:PJT) and its peers.
Shares of intimate wear and beauty retailer Victoria’s Secret (NYSE:VSCO)
jumped 4.3% in the afternoon session after it received positive attention from Wall Street analysts, including a new price target from JP Morgan.
Shares of leading data storage manufacturer Western Digital (NASDAQ: WDC)
jumped 4.6% in the afternoon session after the company announced it is immediately increasing prices across its entire range of hard disk drives (HDDs), citing unprecedented demand.
Shares of equipment rental company Herc Holdings (NYSE:HRI) jumped 2.4% in the afternoon session after the stock extended its positive momentum as the company completed the integration of its $5.3 billion acquisition of H&E Equipment Solutions.
Shares of auto parts and accessories retailer Advance Auto Parts (NYSE:AAP) jumped 2.7% in the afternoon session after Morgan Stanley raised its price target on the stock.
A notable capital reallocation is underway in global financial markets, with investors increasingly pulling funds from the United States and channeling them into European equities throughout 2025. This significant shift is primarily driven by the compelling valuation differential between the two regions; European stocks are perceived as significantly undervalued, offering
As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation among traders and analysts as the weakest month for equities, a phenomenon widely dubbed the "September Effect." This recurring statistical
The global stock markets are currently undergoing a profound and accelerating transformation, driven by the relentless march of Artificial Intelligence (AI) and related technological advancements. This "AI revolution" is not merely an incremental shift but a fundamental reordering of investment strategies, market valuations, and the very mechanisms of trade, with
As the U.S. economy navigates a complex landscape of persistent inflation and a softening labor market, the financial world is holding its breath in anticipation of a pivotal shift in monetary policy. The Federal Reserve is widely expected to initiate a series of interest rate cuts in the latter
The global anti-obesity drug market is experiencing an unprecedented surge, driven by groundbreaking advancements in pharmacotherapy, particularly the advent of highly effective GLP-1 receptor agonists. These revolutionary medications, capable of achieving significant weight loss, are not only transforming the treatment landscape for millions but also igniting a fierce battle among
